Theravance Biopharma (TBPH) Return on Invested Capital [ROIC] (2019 - 2022)
Theravance Biopharma's Return on Invested Capital [ROIC] came in at -397.92% for Q2 2022, up 215.29 percentage points from -613.21% a year earlier and up 66.59 percentage points from the prior quarter.
Powered by 
Analysis
Theravance Biopharma (TBPH) Return on Invested Capital [ROIC] (2019 - 2022) Analysis & Trends
For FY2021, Theravance Biopharma's Return on Invested Capital [ROIC] was -372.83%, up 244.17 percentage points from FY2020.
- Going back by year, Return on Invested Capital [ROIC] was -616.99% in FY2020 (-348.00 pp) and -268.99% in FY2019.
- The five-year range for quarterly Return on Invested Capital [ROIC] is -926.32% (Q4 2019) to -141.45% (Q2 2020).
- Year-over-year, Return on Invested Capital [ROIC] increased in four of the last eight quarters, with an average year-over-year change of -7.27 percentage points.
- The fastest year-over-year change in Return on Invested Capital [ROIC] over five years came in Q4 2020 (a gain of 652.54 percentage points), and the weakest in Q2 2021 (a drop of 471.76 percentage points).
- Business Quant data shows TBPH's Return on Invested Capital [ROIC] at -464.51% (Q1 2022), -450.96% (Q4 2021) and -368.28% (Q3 2021) in the three quarters before Q2 2022.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | ROIC (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,076.25 Bn | 1,044.84 Bn | 19.71 Bn | 37.16% |
| 2 | Johnson & Johnson | 617.18 Bn | 535.70 Bn | 17.26 Bn | 16.10% |
| 3 | AbbVie | 464.58 Bn | 437.73 Bn | 12.70 Bn | 18.68% |
| 4 | Merck | 356.04 Bn | 310.47 Bn | 12.21 Bn | 3.56% |
| 5 | Novartis Ag | 269.07 Bn | 224.94 Bn | 11.24 Bn | 21.95% |
| 6 | Astrazeneca | 243.21 Bn | 216.77 Bn | 12.86 Bn | 28.83% |
| 7 | Amgen | 217.88 Bn | 173.28 Bn | 7.24 Bn | 14.33% |
| 8 | Gilead Sciences | 179.62 Bn | 153.74 Bn | 6.22 Bn | -5.97% |
| 9 | Pfizer | 158.45 Bn | 105.40 Bn | 10.94 Bn | 13.44% |
| 10 | Theravance Biopharma | 883.70 Mn | -543.66 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2022 | -397.92% |
| Mar 31, 2022 | -464.51% |
| Dec 31, 2021 | -450.96% |
| Sep 30, 2021 | -368.28% |
| Jun 30, 2021 | -613.21% |
| Mar 31, 2021 | -588.71% |
| Dec 31, 2020 | -273.79% |
| Sep 30, 2020 | -197.27% |
| Jun 30, 2020 | -141.45% |
| Mar 31, 2020 | -222.03% |
| Dec 31, 2019 | -926.32% |
| Sep 30, 2019 | -333.74% |
| Jun 30, 2019 | -226.76% |
| Mar 31, 2019 | -160.43% |
API Access
Theravance Biopharma Return on Invested Capital [ROIC] API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "return-on-invested-capital-[roic]", "ticker": "TBPH", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=return-on-invested-capital-%5Broic%5D&ticker=TBPH&period=max&api_key=YOUR_API_KEY");
const data = await res.json();